Cargando…

Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China

BACKGROUND: Hepatitis E virus (HEV) is of global significance. HEV is a common cause of acute hepatitis in China. One of the major unanswered questions about HEV is the persistence of antibodies after infection and vaccination. METHODS: We examined antibody persistence 6.5 years after HEV exposures...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kmush, Brittany L, Yu, Huan, Huang, Shoujie, Zhang, Xuefeng, Wu, Ting, Nelson, Kenrad E, Labrique, Alain B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475590/ https://www.ncbi.nlm.nih.gov/pubmed/31024978 http://dx.doi.org/10.1093/ofid/ofz144

Ejemplares similares

Erratum: Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China
por: Kmush, Brittany L, et al.
Publicado: (2019)

A 10-Year Immunopersistence Study of Hepatitis E Antibodies in Rural Bangladesh
por: Kmush, Brittany L, et al.
Publicado: (2018)

An Exploratory Case Control Study of Risk Factors for Hepatitis E in Rural Bangladesh
por: Labrique, Alain B., et al.
Publicado: (2013)

Two Generations of “Gold Standards”: The Impact of a Decade in Hepatitis E Virus Testing Innovation on Population Seroprevalence
por: Kmush, Brittany L., et al.
Publicado: (2015)

A systematic review of the epidemiology of hepatitis E virus in Africa
por: Kim, Jong-Hoon, et al.
Publicado: (2014)

Erratum to: A systematic review of the epidemiology of hepatitis E virus in Africa
por: Kim, Jong-Hoon, et al.
Publicado: (2017)

Hepatitis E, a Vaccine-Preventable Cause of Maternal Deaths
por: Labrique, Alain B., et al.
Publicado: (2012)

Hepatitis E Virus Infection Among Solid Organ Transplant Recipients at a North American Transplant Center
por: Sue, Paul K., et al.
Publicado: (2016)

Hepatitis E Vaccine to Prevent Morbidity and Mortality During Epidemics
por: Nelson, Kenrad E., et al.
Publicado: (2014)

Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi
por: Taha, Taha E., et al.
Publicado: (2015)

Hepatitis E vaccine—Illuminating the barriers to use
por: Lynch, Julia A., et al.
Publicado: (2023)

1736 Arsenic enhances immune dysfunction and susceptibility to viral infection during pregnancy
por: Heaney, Christopher, et al.
Publicado: (2014)

Seroprevalence of hepatitis E virus antibodies in adults and children from upstate New York: A cross-sectional study
por: Kmush, Brittany L., et al.
Publicado: (2021)

Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2
por: Grandjean, Louis, et al.
Publicado: (2021)

Persistent Challenges in the Hepatitis C Virus Care Continuum for Patients in a Central Texas Public Health System
por: Reader, Shane W, et al.
Publicado: (2020)

Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis B
por: Brakenhoff, Sylvia M, et al.
Publicado: (2022)

Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus
por: Fisher, Dennis G., et al.
Publicado: (2015)

Persistence of Neutralizing Antibodies and Clinical Protection up to 12 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Elderly
por: Collarino, Rocco, et al.
Publicado: (2022)

Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy
por: Ruggiero, Alessandra, et al.
Publicado: (2018)

Pre-existence and Persistence of Resistant Minority Hepatitis C Virus Variants in Genotype 1-Infected Patients Treated With Simeprevir/Peginterferon/Ribavirin
por: Fevery, Bart, et al.
Publicado: (2016)

Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART
por: Riddler, Sharon A, et al.
Publicado: (2018)

The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01(E) Malaria Vaccine( )
por: Sagara, Issaka, et al.
Publicado: (2021)

Seroprevalence of Hepatitis E Virus Infection Among People Living With HIV in the Central African Republic
por: Demi Sibiro, Ornella Anne, et al.
Publicado: (2018)

Screening Utility, Local Perceptions, and Care-seeking for Reported Jaundeesh among Respondents Lacking Signs of Icterus in Rural Bangladesh
por: Hossain, Mohammad Z., et al.
Publicado: (2013)

Renal Safety of Long-term Tenofovir Disoproxil Fumarate Treatment in Patients With Chronic Hepatitis B
por: Woldemedihn, Gezahegn M, et al.
Publicado: (2023)

A Study of Viral Hepatitis E Infection in a Tertiary Care Hospital in Mysore, South India
por: Murthy, Karkala Achutha Sudharshana, et al.
Publicado: (2014)

Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir
por: Cruchet, Romuald, et al.
Publicado: (2020)

Peginterferon and Entecavir Combination Therapy Improves Outcome of Non–Early Response Hepatitis B e Antigen–Positive Patients
por: Chen, Lu, et al.
Publicado: (2020)

Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion
por: Chu, Carissa E., et al.
Publicado: (2016)

Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies
por: Verstrepen, Babs E., et al.
Publicado: (2011)

Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study
por: den Hartog, Gerco, et al.
Publicado: (2021)

Single Clinical Practice's Report of Testing Initiation, Antibody Clearance, and Transmission of Hepatitis C Virus (HCV) in Infants of Chronically HCV-Infected Mothers
por: Bal, Aswine, et al.
Publicado: (2016)

Setting a Course for Preventing Hepatitis E in Low and Lower-Middle-Income Countries: A Systematic Review of Burden and Risk Factors
por: Koyuncu, Aybüke, et al.
Publicado: (2021)

Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS)
por: Wyles, David L, et al.
Publicado: (2023)

Half-life Estimation of Pertussis-Specific Maternal Antibodies in (Pre)Term Infants After In-Pregnancy Tetanus, Diphtheria, Acellular Pertussis Vaccination
por: Embacher, Stefan, et al.
Publicado: (2023)

Persistent Symptoms in Patients Recovering From COVID-19 in Denmark
por: Leth, Steffen, et al.
Publicado: (2021)

Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels
por: Zeng, Qing-Lei, et al.
Publicado: (2020)

Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study
por: Barocas, Joshua A, et al.
Publicado: (2021)

Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines
por: Capeding, Maria Rosario, et al.
Publicado: (2018)

Long-Term Sentinel Surveillance for Enterotoxigenic Escherichia coli and Non-O157 Shiga Toxin-Producing E. coli in Minnesota
por: Medus, Carlota, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jbukpm5vet8nc9uo14nu4slnui